Ypsomed AG is a Swiss multinational medical technology company that develops and manufactures injection and infusion systems for self-medication. The company primarily focuses on diabetes care and biotechnology, providing tailored self-care solutions such as insulin pens, auto-injectors, and infusion pumps. Ypsomed partners with pharmaceutical and biotech companies globally to enhance the quality of life for individuals with chronic conditions.